273 related articles for article (PubMed ID: 15665282)
1. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
3. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
7. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
8. "Dub"bing a tumor suppressor pathway.
Niedzwiedz W; Patel KJ
Cancer Cell; 2005 Feb; 7(2):114-5. PubMed ID: 15710323
[TBL] [Abstract][Full Text] [Related]
9. X-linked inheritance of Fanconi anemia complementation group B.
Meetei AR; Levitus M; Xue Y; Medhurst AL; Zwaan M; Ling C; Rooimans MA; Bier P; Hoatlin M; Pals G; de Winter JP; Wang W; Joenje H
Nat Genet; 2004 Nov; 36(11):1219-24. PubMed ID: 15502827
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
[TBL] [Abstract][Full Text] [Related]
11. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
12. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
13. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
14. Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M.
Bakker ST; van de Vrugt HJ; Rooimans MA; Oostra AB; Steltenpool J; Delzenne-Goette E; van der Wal A; van der Valk M; Joenje H; te Riele H; de Winter JP
Hum Mol Genet; 2009 Sep; 18(18):3484-95. PubMed ID: 19561169
[TBL] [Abstract][Full Text] [Related]
15. Interaction of FANCD2 and NBS1 in the DNA damage response.
Nakanishi K; Taniguchi T; Ranganathan V; New HV; Moreau LA; Stotsky M; Mathew CG; Kastan MB; Weaver DT; D'Andrea AD
Nat Cell Biol; 2002 Dec; 4(12):913-20. PubMed ID: 12447395
[TBL] [Abstract][Full Text] [Related]
16. The Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage.
Dequen F; St-Laurent JF; Gagnon SN; Carreau M; Desnoyers S
Comp Biochem Physiol B Biochem Mol Biol; 2005 Aug; 141(4):453-60. PubMed ID: 15979372
[TBL] [Abstract][Full Text] [Related]
17. Fancd2 functions in a double strand break repair pathway that is distinct from non-homologous end joining.
Houghtaling S; Newell A; Akkari Y; Taniguchi T; Olson S; Grompe M
Hum Mol Genet; 2005 Oct; 14(20):3027-33. PubMed ID: 16135554
[TBL] [Abstract][Full Text] [Related]
18. Impaired removal of DNA interstrand cross-link in Nijmegen breakage syndrome and Fanconi anemia, but not in BRCA-defective group.
Tsuchida K; Komatsu K
Cancer Sci; 2008 Nov; 99(11):2238-43. PubMed ID: 18771529
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.
Houghtaling S; Timmers C; Noll M; Finegold MJ; Jones SN; Meyn MS; Grompe M
Genes Dev; 2003 Aug; 17(16):2021-35. PubMed ID: 12893777
[TBL] [Abstract][Full Text] [Related]
20. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
